SALMON EVOLUTION ASA financials
SALMON EVOLUTION ASA
549300P2OB7L255PF765 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Employee benefits expense | NOK 68.0M | NOK 76.1M |
| Raw materials & consumables used | NOK 200.9M | NOK 126.2M |
| Operating profit (EBIT) | -NOK 15.2M | -NOK 110.5M |
| Net finance income / (cost) | -NOK 32.2M | -NOK 35.2M |
| Finance costs | NOK 52.6M | NOK 49.6M |
| Profit before tax | -NOK 47.4M | -NOK 145.8M |
| Income tax expense | NOK 0 | NOK 0 |
| Profit for the year | -NOK 47.4M | -NOK 145.8M |
| Total comprehensive income | -NOK 47.6M | -NOK 146.6M |
| Per share | ||
| Basic EPS | NOK -0.11 | NOK -0.37 |
| Diluted EPS | NOK -0.11 | NOK -0.37 |
| Free cash flow / share | NOK -0.73 | NOK -1.27 |
| Cash flow statement | ||
| Net cash from operating activities | NOK 43.3M | -NOK 124.4M |
| Net cash from investing activities | -NOK 342.6M | -NOK 338.4M |
| Purchase of PP&E (capex) | NOK 358.6M | NOK 375.7M |
| Purchase of intangibles | NOK 12.2M | NOK 7.2M |
| Net cash from financing activities | NOK 342.3M | NOK 570.5M |
| Proceeds from borrowings | NOK 50.2M | NOK 104.9M |
| Repayments of borrowings | NOK 900.0K | NOK 0 |
| Lease liability payments | NOK 5.4M | NOK 0 |
| Balance sheet | ||
| Total assets | NOK 3.18B | NOK 2.71B |
| Non-current assets | NOK 2.42B | NOK 2.08B |
| Right-of-use assets | NOK 17.9M | NOK 12.1M |
| Intangible assets & goodwill | NOK 81.1M | NOK 72.3M |
| Current assets | NOK 768.6M | NOK 633.1M |
| Inventories | NOK 12.9M | NOK 8.4M |
| Trade & other receivables | NOK 90.5M | NOK 40.5M |
| Cash & equivalents | NOK 429.5M | NOK 386.4M |
| Total equity | NOK 2.22B | NOK 1.92B |
| Non-current liabilities | NOK 582.4M | NOK 586.9M |
| Long-term borrowings | NOK 569.1M | NOK 570.0M |
| Lease liabilities (non-current) | NOK 9.7M | NOK 8.2M |
| Current liabilities | NOK 378.7M | NOK 202.0M |
| Short-term borrowings | NOK 158.5M | NOK 103.3M |
| Lease liabilities (current) | NOK 5.3M | NOK 4.3M |
| Derived metrics | ||
| Free cash flow | -NOK 315.3M | -NOK 500.2M |
| Return on equity | -2.1% | -7.6% |
| Cash conversion ratio | -0.91× | 0.85× |
| Capex coverage | 0.12× | -0.33× |
| Other reported items | ||
| Adjustments For Decrease Increase In Other Operating Receivables | -NOK 11.1M | NOK 33.8M |
| Adjustments For Decrease Increase In Trade Account Receivable | -NOK 50.0M | -NOK 15.6M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | NOK 76.1M | NOK 46.7M |
| Adjustments For Finance Income Cost | -NOK 32.2M | -NOK 35.2M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -NOK 10.5M | NOK 20.1M |
| Adjustments For Increase Decrease In Other Current Liabilities | -NOK 306.0K | NOK 6.9M |
| Adjustments For Increase Decrease In Trade Account Payable | NOK 65.6M | NOK 12.3M |
| Adjustments For Sharebased Payments | NOK 726.0K | NOK 2.4M |
| Changes In Inventories of Finished Goods and Work In Progress | -NOK 29.6M | -NOK 78.5M |
| Construction In Progress | NOK 481.8M | NOK 70.8M |
| Current Biological Assets | NOK 171.0M | NOK 153.8M |
| Current Derivative Financial Assets | NOK 13.6M | NOK 12.9M |
| Current Payables On Social Security and Taxes Other Than Income Tax | NOK 7.1M | NOK 8.3M |
| Deferred Tax Assets | NOK 0 | NOK 415.0K |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | NOK 76.1M | NOK 46.7M |
| Equity and Liabilities | NOK 3.18B | NOK 2.71B |
| Finance Income | NOK 28.2M | NOK 21.5M |
| Gains Losses On Fair Value Adjustment Biological Assets | -NOK 10.5M | NOK 20.1M |
| Increase Decrease In Cash and Cash Equivalents | NOK 43.1M | NOK 107.6M |
| Increase Decrease Through Exercise of Options | — | NOK 0 |
| Increase Decrease Through Sharebased Payment Transactions | NOK 726.0K | — |
| Increase Decrease Through Transactions With Owners | NOK 350.2M | NOK 503.4M |
| Investment Accounted For Using Equity Method | NOK 10.7M | NOK 18.7M |
| Issued Capital | NOK 23.1M | NOK 20.7M |
| Liabilities | NOK 961.1M | NOK 788.9M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -NOK 178.0K | -NOK 861.0K |
| Other Current Liabilities | NOK 14.4M | NOK 14.6M |
| Other Current Receivables | NOK 51.1M | NOK 31.1M |
| Other Expense By Nature | NOK 160.8M | NOK 128.6M |
| Other Noncurrent Assets | NOK 0 | NOK 54.0M |
| Other Noncurrent Liabilities | NOK 3.6M | NOK 8.7M |
| Other Property Plant and Equipment | NOK 1.82B | NOK 1.85B |
| Other Reserves | NOK 11.5M | NOK 10.8M |
| Other Revenue | NOK 3.8M | NOK 15.1M |
| Payments For Share Issue Costs | NOK 15.6M | NOK 24.0M |
| Proceeds From Government Grants Classified As Investing Activities | NOK 764.0K | NOK 24.1M |
| Proceeds From Issuing Shares | NOK 365.0M | NOK 525.0M |
| Reserve of Sharebased Payments | NOK 0 | NOK 0 |
| Retained Earnings | -NOK 226.4M | -NOK 235.4M |
| Revenue and Operating Income | NOK 471.6M | NOK 168.4M |
| Revenue From Sale of Goods | NOK 467.7M | NOK 153.3M |
| Share Issue Related Cost | NOK 15.6M | NOK 24.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -NOK 7.8M | -NOK 7.1M |
| Share Premium | NOK 2.42B | NOK 2.12B |
| Trade and Other Current Payables To Trade Suppliers | NOK 193.4M | NOK 71.5M |
Every line item above is a fact tagged in SALMON EVOLUTION ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (NOK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.